PERFECT trial results: Combining neoadjuvant chemoradiotherapy with atezolizumab is feasible in resectable esophageal adenocarcinoma

Detalles Bibliográficos
Autor principal: Zhang, Liyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201525/
https://www.ncbi.nlm.nih.gov/pubmed/33973394
http://dx.doi.org/10.1111/1759-7714.13972
_version_ 1783707830020210688
author Zhang, Liyi
author_facet Zhang, Liyi
author_sort Zhang, Liyi
collection PubMed
description
format Online
Article
Text
id pubmed-8201525
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley & Sons Australia, Ltd
record_format MEDLINE/PubMed
spelling pubmed-82015252021-06-16 PERFECT trial results: Combining neoadjuvant chemoradiotherapy with atezolizumab is feasible in resectable esophageal adenocarcinoma Zhang, Liyi Thorac Cancer Editorial John Wiley & Sons Australia, Ltd 2021-05-10 2021-06 /pmc/articles/PMC8201525/ /pubmed/33973394 http://dx.doi.org/10.1111/1759-7714.13972 Text en © 2021 The Author. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Editorial
Zhang, Liyi
PERFECT trial results: Combining neoadjuvant chemoradiotherapy with atezolizumab is feasible in resectable esophageal adenocarcinoma
title PERFECT trial results: Combining neoadjuvant chemoradiotherapy with atezolizumab is feasible in resectable esophageal adenocarcinoma
title_full PERFECT trial results: Combining neoadjuvant chemoradiotherapy with atezolizumab is feasible in resectable esophageal adenocarcinoma
title_fullStr PERFECT trial results: Combining neoadjuvant chemoradiotherapy with atezolizumab is feasible in resectable esophageal adenocarcinoma
title_full_unstemmed PERFECT trial results: Combining neoadjuvant chemoradiotherapy with atezolizumab is feasible in resectable esophageal adenocarcinoma
title_short PERFECT trial results: Combining neoadjuvant chemoradiotherapy with atezolizumab is feasible in resectable esophageal adenocarcinoma
title_sort perfect trial results: combining neoadjuvant chemoradiotherapy with atezolizumab is feasible in resectable esophageal adenocarcinoma
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201525/
https://www.ncbi.nlm.nih.gov/pubmed/33973394
http://dx.doi.org/10.1111/1759-7714.13972
work_keys_str_mv AT zhangliyi perfecttrialresultscombiningneoadjuvantchemoradiotherapywithatezolizumabisfeasibleinresectableesophagealadenocarcinoma

Ejemplares similares